Veterinary Medicines

HEMOSILATE 125 mg/ml solution for injection

Authorised
  • Etamsylate
Download as PDF

Product identification

Medicine name:
HEMOSILATE 125 mg/ml solution for injection
Hemosilate vet 125 mg/ml Injektionsvätska, lösning
Active substance:
  • Etamsylate
Target species:
  • Cattle
  • Sheep
  • Goat
  • Pig
  • Horse
  • Dog
  • Cat
Route of administration:
  • Intravenous use
  • Intramuscular use

Product details

Active substance and strength:
  • Etamsylate
    125.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        no withdrawal period
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        no withdrawal period
      • Milk
        0
        day
    • Goat
      • Meat and offal
        no withdrawal period
      • Milk
        0
        day
    • Pig
      • Meat and offal
        no withdrawal period
    • Horse
      • Meat and offal
        no withdrawal period
      • Milk
        0
        day
    • Dog
    • Cat
  • Intramuscular use
    • Cattle
      • Meat and offal
        no withdrawal period
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        no withdrawal period
      • Milk
        0
        day
    • Goat
      • Meat and offal
        no withdrawal period
      • Milk
        0
        day
    • Pig
      • Meat and offal
        no withdrawal period
    • Horse
      • Meat and offal
        no withdrawal period
      • Milk
        0
        day
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QB02BX01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Sweden
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ecuphar Veterinaria S.L.U.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 58777
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0281/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 22/12/2023
Download
Swedish (PDF)
Published on: 16/11/2022
Download

Package Leaflet

English (PDF)
Published on: 22/12/2023
Download
Swedish (PDF)
Published on: 16/11/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 16/11/2022
Download

eu-PUAR-esv0281001-dcp-hemosilate-125-mg-ml-solution-for-injection-en.pdf

English (PDF)
Published on: 22/12/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."